X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare JUBILANT LIFE SCIENCES with GSK Pharma - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

JUBILANT LIFE SCIENCES vs GSK PHARMA - Comparison Results

GSK PHARMA 
   Change

GSK Pharma is one of the leading MNC pharma companies in the Indian market. It is a 50.7% subsidiary of GlaxoSmithKline Plc, one of the world's largest pharma companies. GSK Pharma's product portfolio boasts of some of the leading brands like Augment... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    JUBILANT LIFE SCIENCES GSK PHARMA JUBILANT LIFE SCIENCES/
GSK PHARMA
 
P/E (TTM) x 27.5 63.5 43.3% View Chart
P/BV x 5.6 10.2 55.3% View Chart
Dividend Yield % 0.3 1.2 26.0%  

Financials

 JUBILANT LIFE SCIENCES   GSK PHARMA
EQUITY SHARE DATA
    JUBILANT LIFE SCIENCES
Mar-14
GSK PHARMA
Mar-17
JUBILANT LIFE SCIENCES/
GSK PHARMA
5-Yr Chart
Click to enlarge
High Rs1873,838 4.9%   
Low Rs652,637 2.5%   
Sales per share (Unadj.) Rs364.3354.2 102.9%  
Earnings per share (Unadj.) Rs6.839.8 17.2%  
Cash flow per share (Unadj.) Rs24.542.9 57.1%  
Dividends per share (Unadj.) Rs3.0030.00 10.0%  
Dividend yield (eoy) %2.40.9 257.0%  
Book value per share (Unadj.) Rs164.9236.9 69.6%  
Shares outstanding (eoy) m159.2884.70 188.1%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.39.1 3.8%   
Avg P/E ratio x18.481.4 22.6%  
P/CF ratio (eoy) x5.175.5 6.8%  
Price / Book Value ratio x0.813.7 5.6%  
Dividend payout %43.875.4 58.1%   
Avg Mkt Cap Rs m20,061274,216 7.3%   
No. of employees `0006.24.7 131.7%   
Total wages/salary Rs m11,0524,830 228.8%   
Avg. sales/employee Rs Th9,383.06,387.0 146.9%   
Avg. wages/employee Rs Th1,786.91,028.3 173.8%   
Avg. net profit/employee Rs Th176.3717.1 24.6%   
INCOME DATA
Net Sales Rs m58,03430,000 193.4%  
Other income Rs m191728 26.2%   
Total revenues Rs m58,22430,728 189.5%   
Gross profit Rs m5,7864,190 138.1%  
Depreciation Rs m2,812263 1,069.1%   
Interest Rs m3,2370-   
Profit before tax Rs m-724,655 -1.5%   
Minority Interest Rs m-2860-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m2,145457 469.3%   
Tax Rs m6961,744 39.9%   
Profit after tax Rs m1,0903,368 32.4%  
Gross profit margin %10.014.0 71.4%  
Effective tax rate %-965.937.5 -2,578.1%   
Net profit margin %1.911.2 16.7%  
BALANCE SHEET DATA
Current assets Rs m29,28016,742 174.9%   
Current liabilities Rs m38,9127,202 540.3%   
Net working cap to sales %-16.631.8 -52.2%  
Current ratio x0.82.3 32.4%  
Inventory Days Days8452 162.9%  
Debtors Days Days5121 243.9%  
Net fixed assets Rs m55,7128,635 645.2%   
Share capital Rs m155847 18.2%   
"Free" reserves Rs m20,96819,222 109.1%   
Net worth Rs m26,26520,069 130.9%   
Long term debt Rs m17,16910 171,688.0%   
Total assets Rs m88,60630,038 295.0%  
Interest coverage x1.0NM-  
Debt to equity ratio x0.70 131,182.9%  
Sales to assets ratio x0.71.0 65.6%   
Return on assets %4.911.2 43.6%  
Return on equity %4.216.8 24.7%  
Return on capital %11.625.5 45.4%  
Exports to sales %37.80-   
Imports to sales %16.50-   
Exports (fob) Rs m21,933NA-   
Imports (cif) Rs m9,567NA-   
Fx inflow Rs m22,004528 4,167.4%   
Fx outflow Rs m11,7497,193 163.3%   
Net fx Rs m10,255-6,665 -153.9%   
CASH FLOW
From Operations Rs m8,0262,360 340.1%  
From Investments Rs m-1,7443,008 -58.0%  
From Financial Activity Rs m-4,447-5,108 87.1%  
Net Cashflow Rs m1,834260 704.7%  

Share Holding

Indian Promoters % 45.6 0.0 -  
Foreign collaborators % 3.5 50.7 6.9%  
Indian inst/Mut Fund % 8.7 10.2 85.3%  
FIIs % 21.2 23.8 89.1%  
ADR/GDR % 0.0 0.0 -  
Free float % 21.1 15.4 137.0%  
Shareholders   23,815 102,036 23.3%  
Pledged promoter(s) holding % 15.9 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare JUBILANT LIFE SCIENCES With:   WOCKHARDT LTD.  J.B.CHEMICALS  ORCHID PHARMA LTD  DIVIS LABORATORIES  FULFORD INDIA  

Compare JUBILANT LIFE SCIENCES With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Finishes Marginally Lower; Capital Goods & Realty Stocks Fall(Closing)

Indian share markets witnessed selling pressure in the final hour of trade to finish just below the dotted line. At the closing bell, the BSE Sensex closed lower by 71 points.

Related Views on News

Most Popular

Follow India's Super Investors to Make Big Money in the Market Crash(The 5 Minute Wrapup)

Feb 8, 2018

Has the sell-off in the markets left India's super investors unduly worried?

The Era of Easy Money is Coming to an End. What Happens Now?(Vivek Kaul's Diary)

Feb 9, 2018

The easy money policy of the Federal Reserve of the United States, which drove up stock markets all over the world, is ending, with the Federal Reserve looking to shrink its balance sheet.

The Markets Want Your Money. Don't Give It to Them.(Smart Contrarian)

Feb 9, 2018

MFs are having a gala time taking money from over-eager investors and funneling it into equities. Smart investors, though, know better than to do that.

The Big Gamble(The Honest Truth)

Feb 15, 2018

Once you accept the fact that elections are round the corner and that this budget is geared to reach a 40% target, everything makes sense.

Rising Dominance of Mutual Funds(Chart Of The Day)

Feb 8, 2018

Domestic money flow into Indian equities surpassed foreign fund flows in the recent years. But will it continue in volatile market?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

JUBILANT LIFE SCIENCES SHARE PRICE


Feb 20, 2018 (Close)

TRACK JUBILANT LIFE SCIENCES

  • Track your investment in JUBILANT LIFE SCIENCES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON JUBILANT LIFE SCIENCES

JUBILANT LIFE SCIENCES - IPCA LABS COMPARISON

COMPARE JUBILANT LIFE SCIENCES WITH

MARKET STATS